Well, probuphine got its nice press as well. But it didn't impress insurance companies.
I welcome Indivior. The more press the better. They can perhaps open doors that Braeburn could not in terms of reimbursement. And once insurance companies accept the idea of paying for implant/injectables, I would think implants would become the preferred treatment methodology because they are cheaper, and require fewer visits to the doctor.
News 
Market Data 
Discover 
